
Dayclazide Total 60mg/15mg/500mg Tablet SR
Marketer
Daylon Healthcare
Salt Composition
Gliclazide (60mg) + Pioglitazone (15mg) + Metformin (500mg)
Overview Dayclazide Total 60mg/15mg/500mg Tablet SR
Glucotrim Triple Action 60mg/15mg/500mg Extended-Release Tablets are prescribed for managing type 2 diabetes. This medication assists adults in regulating blood glucose. Glucotrim Triple Action should be ingested with meals, ideally at the same time daily. Dosage is determined by your physician and may be adjusted based on your glucose readings. Continue taking this medication as directed, even if you feel well or your blood sugar is controlled. Discontinuing without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This medication is one element of a comprehensive diabetes management plan, encompassing a healthy diet, regular exercise, and weight management as advised by your doctor. Lifestyle choices are crucial in diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, and headache. Maintain regular meals and carry readily available glucose, such as sweets or juice, to counter this. Alcohol consumption should be limited due to its interaction with the medication. Additional potential side effects include nausea, altered taste, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before starting treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring, as well as blood tests to assess blood cell counts and liver function, are recommended.
Uses of Dayclazide Total 60mg/15mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Dayclazide Total 60mg/15mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Dayclazide Total 60mg/15mg/500mg Extended-Release tablets should be taken with meals.
Common Side effects of Dayclazide Total 60mg/15mg/500mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Dizziness
- Headache
- Nausea
- Vomiting
- Diarrhea
- Flatulence
- Upper respiratory tract infection
- Bronchitis (inflammation of the airways)
- Anemia (low number of red blood cells)
- Edema (swelling)
How to use Dayclazide Total 60mg/15mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire Dayclazide Total 60mg/15mg/500mg Tablet SR whole; do not chew, crush, or fracture it. Administer this medication with food.
How Dayclazide Total 60mg/15mg/500mg Tablet SR works:
Dayclazide SR tablets (60mg/15mg/500mg) combine gliclazide, pioglitazone, and metformin—three antidiabetic agents with distinct actions—to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Gliclazide (a sulfonylurea) stimulates pancreatic insulin secretion, reducing blood glucose. Pioglitazone (a thiazolidinedione) enhances insulin sensitivity. Metformin (a biguanide) acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dayclazide Total 60mg/15mg/500mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Dayclazide 60mg/15mg/500mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. Prescribing will depend on your physician's assessment of the benefits versus potential hazards. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Dayclazide 60mg/15mg/500mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The extended-release Dayclazide 60mg/15mg/500mg tablet is likely contraindicated for individuals with renal impairment and should be omitted. Medical advice is recommended.
LiverUNSAFE
Concomitant use of Dayclazide Total 60mg/15mg/500mg SR tablets is likely contraindicated in individuals with hepatic impairment and should be avoided. Physician consultation is recommended.
What if you forget to take Dayclazide Total 60mg/15mg/500mg Tablet SR :
Should you forget a dose of Dayclazide Total 60mg/15mg/500mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dayclazide Total 60mg/15mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
